Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/10702
Title: Therapeutic vaccines for autoimmune Diseases
Authors: PANNEMANS, Kim 
HELLINGS, Niels 
STINISSEN, Piet 
Issue Date: 2010
Publisher: Elsevier
Source: Drug Discovery Today: Therapeutic Strategies, 6(1), p. 39-44
Abstract: The immune system has developed several checkpoints to prevent the induction of autoimmune diseases like multiple sclerosis and rheumatoid arthritis. Autoreactive T cells are negatively selected in the thymus but can escape this selection procedure. Peripherally, they are further controlled by homeostatic mechanisms and regulatory T cells (Tregs). Genetic and exogenous factors as well as a disbalanced functioning of Tregs may all influence these checkpoints and contribute to the breakdown of tolerance against ‘self’. Re-establishment of tolerance can be achieved by different vaccination strategies, which are divided into three major groups based on the composition of the vaccine: DNA vaccination, peptide-based-vaccination and T cell vaccination. This review summarizes the mechanisms, clinical trials and pros and cons of these different vaccination strategies.
Document URI: http://hdl.handle.net/1942/10702
ISSN: 1359-6446
e-ISSN: 1878-5832
DOI: 10.1016/j.ddstr.2009.11.001
Category: A1
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
1-s2.0-S1740677309000278-main.pdf
  Restricted Access
published article 218.76 kBAdobe PDFView/Open    Request a copy
Show full item record

SCOPUSTM   
Citations

2
checked on Sep 3, 2020

Page view(s)

64
checked on May 20, 2022

Download(s)

48
checked on May 20, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.